| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 34.79 | 1112 |
| Intrinsic value (DCF) | 1.49 | -48 |
| Graham-Dodd Method | 4.13 | 44 |
| Graham Formula | 3.10 | 8 |
UV Germi SA is a French company specializing in the design, manufacture, and sale of ultraviolet (UV) disinfection devices for air, water, and surface treatment. Founded in 2009 and headquartered in Saint-Viance, France, the company serves markets in Europe, the Middle East, and North Africa. UV Germi's product portfolio includes solutions for drinking water, wastewater, public swimming pools, rainwater, and industrial water applications in sectors such as food processing, pharmaceuticals, and cosmetics. The company also offers after-sales services, including technical support and maintenance, ensuring long-term customer satisfaction. Operating in the industrial pollution and treatment controls sector, UV Germi plays a critical role in water sanitation and hygiene, addressing growing global concerns over waterborne pathogens and environmental sustainability. With a market capitalization of approximately €7.57 million, UV Germi is a niche player in the UV disinfection market, leveraging its expertise to cater to specialized industrial and municipal needs.
UV Germi SA presents a niche investment opportunity in the UV disinfection market, with a focus on water treatment applications. The company's €8.51 million revenue and €709,927 net income in the latest fiscal year indicate stable operations, supported by a strong cash position of €4.26 million and minimal debt (€91,992). However, the lack of dividend payouts and a negative beta (-0.241) suggest low correlation with broader market movements, which may appeal to risk-averse investors seeking specialized exposure. The company's small market cap and limited geographic reach (primarily France and neighboring regions) pose growth constraints, but increasing global demand for water sanitation solutions could present expansion opportunities. Investors should weigh UV Germi's specialized expertise against its relatively small scale and dependence on industrial and municipal spending cycles.
UV Germi SA operates in a competitive but fragmented market for UV disinfection systems, competing with both large multinationals and smaller regional players. The company's competitive advantage lies in its specialized focus on water treatment applications, particularly in industrial and municipal settings, where its tailored solutions and after-sales services differentiate it from broader competitors. UV Germi's strong cash position and low debt provide financial flexibility, but its small scale limits R&D and marketing resources compared to larger rivals. The company's geographic concentration in France and nearby regions is both a strength (deep local market knowledge) and a weakness (limited global reach). UV Germi's negative beta suggests its performance is less tied to macroeconomic fluctuations, appealing to investors seeking niche industrial exposure. However, the lack of operating cash flow and capital expenditure data raises questions about its ability to fund growth initiatives. The company's ability to capitalize on increasing regulatory demands for water sanitation will be critical to maintaining its competitive position against larger, better-resourced competitors.